Supplementary Figure 1.
B
D1-2 NoInf
D1-2 Inf
D3-4 NoInf
D3-4 Inf
0
50
100
150
200
sCD
127
conc
entr
ation
(ng/
ml)
p < 0.001
IL-7
Con
cent
ratio
n (p
g /
mL)
D1-2 D3-4 HV0
10
20
30
p < 0.001
A
A. Survival curves based on sCD127 (D1) and SAPSII
0 10 20 300
20
40
60
80
100
Days
Perc
ent s
urvi
val
sCD127 ≤ 48.78 - SAPSII ≤ 59
sCD127 ≤ 48.78 - SAPSII > 59
sCD127 > 48.78 - SAPSII > 59
sCD127 > 48.78 - SAPSII ≤ 59
sCD127 ≤ 41.56 - SAPSII ≤ 59
sCD127 ≤ 41.56 - SAPSII > 59
sCD127 > 41.56 - SAPSII > 59
sCD127 > 41.56 - SAPSII ≤ 59
0 10 20 300
20
40
60
80
100
Days
Perc
ent s
urvi
val
B. Survival curves based on sCD127 (D3) and SAPSII
Supplementary Figure 2.
Top Related